Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia SF Taylor, J Kang, IS Brege, IF Tso, A Hosanagar, TD Johnson Biological psychiatry 71 (2), 136-145, 2012 | 320 | 2012 |
Aberrant amygdala–frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder KE Prater, A Hosanagar, H Klumpp, M Angstadt, K Luan Phan Depression and anxiety 30 (3), 234-241, 2013 | 237 | 2013 |
Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder S Dodhia, A Hosanagar, DA Fitzgerald, I Labuschagne, AG Wood, ... Neuropsychopharmacology 39 (9), 2061-2069, 2014 | 223 | 2014 |
Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder SM Gorka, DA Fitzgerald, I Labuschagne, A Hosanagar, AG Wood, ... Neuropsychopharmacology 40 (2), 278-286, 2015 | 155 | 2015 |
Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers VA Diwadkar, D Goradia, A Hosanagar, D Mermon, DM Montrose, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (5), 1349-1354, 2011 | 98 | 2011 |
Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy TW Park, LA Lin, A Hosanagar, A Kogowski, K Paige, ASB Bohnert Journal of addiction medicine 10 (6), 369-381, 2016 | 84 | 2016 |
Are “bath salts” the next generation of stimulant abuse? GS Winder, N Stern, A Hosanagar Journal of Substance Abuse Treatment 44 (1), 42-45, 2013 | 69 | 2013 |
Hippocampal volume development in healthy siblings of childhood-onset schizophrenia patients A Mattai, A Hosanagar, B Weisinger, D Greenstein, R Stidd, L Clasen, ... American Journal of Psychiatry 168 (4), 427-435, 2011 | 62 | 2011 |
A systematic review of psychological interventions for adult and pediatric patients with vocal cord dysfunction L Guglani, S Atkinson, A Hosanagar, L Guglani Frontiers in Pediatrics 2, 82, 2014 | 55 | 2014 |
US trends in registration for medical cannabis and reasons for use from 2016 to 2020: an observational study KF Boehnke, O Dean, RL Haffajee, A Hosanagar Annals of internal medicine 175 (7), 945-951, 2022 | 43 | 2022 |
The addictive potential and challenges with use of the “herbal supplement” kratom: a case report and literature review A Anand, A Hosanagar Pain Medicine 23 (1), 4-9, 2022 | 14 | 2022 |
Acute urinary retention secondary to buprenorphine administration. RT Edwards, C McCormick-Deaton, A Hosanagar The American Journal of Emergency Medicine 32 (1), 109. e1-2, 2013 | 13 | 2013 |
Therapeutic potential of psychedelics in treatment of psychiatric disorders, part 2: review of the evidence A Hosanagar, J Cusimano, R Radhakrishnan The Journal of clinical psychiatry 82 (3), 28214, 2021 | 9 | 2021 |
Gaps in alcohol screening and intervention practices in surgical healthcare: a qualitative study AC Fernandez, TC Guetterman, B Borsari, MJ Mello, J Mellinger, ... Journal of addiction medicine 15 (2), 113-119, 2021 | 8 | 2021 |
Drug misuse in the veterinary setting: an under-recognized Avenue A Anand, A Hosanagar Current Psychiatry Reports 23, 1-5, 2021 | 7 | 2021 |
Ketamine use in child and adolescent psychiatry: emerging data in treatment-resistant depression, insights from adults, and future directions K Ryan, A Hosanagar Current Psychiatry Reports 25 (8), 337-344, 2023 | 2 | 2023 |
Assessment of outcome-based measures of depression care quality in Veterans Health Administration facilities PN Pfeiffer, K Zivin, A Hosanagar, V Panaite, D Ganoczy, HM Kim, T Hofer, ... The Journal of Behavioral Health Services & Research 50 (1), 49-67, 2023 | 2 | 2023 |
Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine A Hosanagar, A Schmale, A LeBlanc Journal of Affective Disorders 282, 252-254, 2021 | 2 | 2021 |
Phenibut use in a patient prescribed Gabapentinoids C Tamarelli, A Hosanagar Pain Medicine 22 (3), 761-762, 2021 | 2 | 2021 |
Pain moderates changes in psychological flexibility but not substance use symptoms during substance use disorder treatment KT Foster, C Ehrnstrom, S Chermack, A Hosanagar Psychiatry research 245, 51-57, 2016 | 2 | 2016 |